Thailand has not yet legalised marijuana but pretty soon Thais will not only be able to grow their own plants but they will be allowed to sell them to the government.

“In the near future, families will be able to plant cannabis trees in their back gardens like any other herb,” Health Minister Anutin Charnvirakul said.

But if you’re American and you’d much rather try other people’s products, then becoming a cannabis tester might be the way to go.

As the cannabis sector grows so does the string of product reviews. You could do it for free – or you could be paid $US36,000 ($52,800) a year.

American Marijuana is accepting applications for anyone interested in becoming a professional cannabis critic. The company said: “this job is 100 per cent for real and it’s an important job”.

But it’s not just about consuming the products. The lucky candidate will also have to create digital content, vlogs and podcasts, including explainers about how the products work.

Heading back Down Under, a senate community affairs committee inquiry is about to receive submissions for an inquiry into the suitability of cannabis for subsidies through the Pharmaceutical Benefits Scheme.

But one government senator, Jonathon Duniam, claimed the Greens, the ones pushing for the inquiry, were ignoring the progress made to date.

Small cap spotlight

It was a quiet week among ASX small caps. The biggest gainer was Suda Pharmaceuticals (ASX:SUD) which got a cash boost of nearly $1m with an R&D tax incentive refund.

Zelda Therapeutics (ASX:ZLD) announced it would take part in a 600-patient clinical trial which aims to reduce pain for advanced cancer sufferers.

And Althea’s (ASX:AGH) Bristol clinic secured a licence from the Care and Quality Commission (CQC) allowing it to now provide home care.

Here’s Stockhead’s latest summary of weekly and annual price performance for ASX-listed cannabis stocks:

Scroll or swipe to reveal table. Click headings to sort:

Code Name Price 1Y % Return 1W % Return Market Cap
SUDA SUDA PHARMACEUTICALS LTD 0.06 -64 20 $7.3M
ESE ESENSE-LAB LTD-CDI 0.012 -71 18 $2.3M
IHL IMPRESSION HEALTHCARE LTD 0.075 248 11 $49.5M
DTZ DOTZ NANO LTD 0.04 -45 8 $9.5M
BDA BOD AUSTRALIA LTD 0.34 -39 6 $31.1M
CP1 CANNPAL ANIMAL THERAPEUTICS 0.125 -7 4 $12.1M
THC THC GLOBAL GROUP LTD 0.42 -23 3 $56.0M
YPB YPB GROUP LTD 0.0065 -65 0 $9.0M
ZLD ZELDA THERAPEUTICS LTD 0.067 26 0 $53.1M
EVE EVE INVESTMENTS LTD 0.005 -29 0 $12.8M
BOT BOTANIX PHARMACEUTICALS LTD 0.11 41 0 $110.9M
WOA WIDE OPEN AGRICULTURE LTD 0.15 7 0 $10.6M
CPH CRESO PHARMA LTD 0.2 -53 0 $30.3M
OBJ OBJ LTD 0.015 -21 0 $27.1M
MDC MEDLAB CLINICAL LTD 0.38 -4 0 $79.7M
PAL PALLA PHARMA LTD 0.83 -31 -1 $100.8M
MRG MURRAY RIVER ORGANICS GROUP 0.07 -15 -1 $30.3M
EOF ECOFIBRE LTD 3.5 272 -3 $1.1B
MXC MGC PHARMACEUTICALS LTD 0.034 -17 -3 $49.2M
IDT IDT AUSTRALIA LTD 0.15 -11 -3 $35.5M
RGI ROTO-GRO INTERNATIONAL LTD 0.155 -66 -3 $20.8M
CLI CROPLOGIC LTD 0.031 35 -3 $12.9M
EN1 ENGAGE:BDR LTD 0.023 -50 -8 $14.3M
RNO RHINOMED LTD 0.2 -5 -9 $33.8M
ECS ECS BOTANICS HOLDINGS LTD 0.051 -51 -9 $23.3M
AGH ALTHEA GROUP HOLDINGS LTD 0.435 18 -9 $102.7M
LSH LIFESPOT HEALTH LTD 0.041 -53 -11 $3.2M
ROO ROOTS SUSTAINABLE AGRICU-CDI 0.039 -82 -11 $5.0M
EXL ELIXINOL GLOBAL LTD 1.15 -42 -14 $145.5M
APH AUSTRALIAN PRIMARY HEMP LTD 0.18 -18 -14 $12.5M
SCU STEMCELL UNITED LTD 0.012 -52 -14 $8.3M
AC8 AUSCANN GROUP HOLDINGS LTD 0.23 -70 -17 $79.3M
CAU CRONOS AUSTRALIA LTD 0.245 -53 -17 $37.3M
MMJ MMJ GROUP HOLDINGS LTD 0.16 -55 -19 $38.1M
CAN CANN GROUP LTD 0.83 -68 -21 $124.1M